ESC Premium Access

Safety and efficacy of single vs. dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation: a propensity matched analysis from the ITER registry

Congress Presentation

About the speaker

Doctor Matteo Bianco

San Luigi Gonzaga University Hospital, Orbassano (Italy)
1 presentation
0 follower

8 more presentations in this session

Transcatheter aortic valve implantation in patients with advanced chronic kidney disease: futility or reliability?

Speaker: Doctor F. Conrotto (Turin, IT)


Multivariate Predictors for Adverse Long Term Outcome after Trancatheter Aortic Valve Implantation

Speaker: Mr A. Berkowitsch (Bad Nauheim, DE)


Comparison of transcatheter aortic valve implantation versus surgical aortic valve replacement and medical treatment: A systematic review and meta-analysis

Speaker: Assistant Professor M. Noutsias (Neuruppin, DE)


Transcatheter aortic valve implantation in high-risk patients with severely stenotic bicuspid versus tricuspid aortic valves


5-year follow-up after transcatheter aortic valve implantation (TAVI) in severe symptomatic aortic stenosis: results from the German TAVI registry

Speaker: Professor R. Zahn (Ludwigshafen, DE)


Access the full session

Transcatheter aortic valves: the evidence is growing

Speakers: Doctor M. Bianco, Doctor F. Conrotto, Mr A. Berkowitsch, Assistant Professor M. Noutsias, Professor R. Zahn

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb